Ocugen Future Growth
Future criteria checks 2/6
Ocugen is forecast to grow earnings and revenue by 47.9% and 74.5% per annum respectively while EPS is expected to grow by 53% per annum.
Key information
47.9%
Earnings growth rate
53.0%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 74.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10 | -63 | -78 | N/A | 2 |
| 12/31/2025 | N/A | -60 | -70 | N/A | 4 |
| 12/31/2024 | 4 | -54 | -68 | N/A | 4 |
| 9/30/2024 | 5 | -51 | -49 | -43 | N/A |
| 6/30/2024 | 7 | -50 | -54 | -46 | N/A |
| 3/31/2024 | 7 | -58 | -66 | -54 | N/A |
| 12/31/2023 | 6 | -63 | -73 | -62 | N/A |
| 9/30/2023 | 7 | -79 | -77 | -68 | N/A |
| 6/30/2023 | 3 | -90 | -76 | -68 | N/A |
| 3/31/2023 | 3 | -86 | -69 | -63 | N/A |
| 12/31/2022 | 2 | -87 | -65 | -60 | N/A |
| 9/30/2022 | N/A | -74 | -59 | -56 | N/A |
| 6/30/2022 | N/A | -63 | -52 | -50 | N/A |
| 3/31/2022 | N/A | -69 | -59 | -58 | N/A |
| 12/31/2021 | N/A | -58 | -49 | -48 | N/A |
| 9/30/2021 | N/A | -48 | -41 | -39 | N/A |
| 6/30/2021 | N/A | -47 | -35 | -34 | N/A |
| 3/31/2021 | 0 | -38 | -16 | -15 | N/A |
| 12/31/2020 | 0 | -34 | -15 | -15 | N/A |
| 6/30/2020 | 0 | -30 | -19 | -19 | N/A |
| 3/31/2020 | N/A | -18 | -19 | -19 | N/A |
| 12/31/2019 | N/A | -20 | -17 | -17 | N/A |
| 9/30/2019 | N/A | -39 | -11 | -11 | N/A |
| 6/30/2019 | N/A | -18 | -12 | -12 | N/A |
| 3/31/2019 | N/A | -19 | -12 | -12 | N/A |
| 12/31/2018 | N/A | -18 | -12 | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2H51 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2H51 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2H51 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2H51's revenue (74.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2H51's revenue (74.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2H51's Return on Equity is forecast to be high in 3 years time